Healthcare -
Biotechnology - NASDAQ - US
$ 2.43
0.206 %
$ 70.2 M
Market Cap
-0.81
P/E
AVTE - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities AVTE - Aerovate Therapeutics, Inc.
46 M
LAST VALUE
-50.86%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR